Insulin-like growth factor-I (IGF-I): Solution properties and NMR chemical shift assignments near physiological pH

Growth Hormone and IGF Research

Volumn 19, Issue 3, 2009, Pages 226-231

  Kuang, Zhihe ^a,b   Yao, Shenggen ^a   McNeil, Kerrie A ^b   Forbes, Briony E ^b   Wallace, John C ^b   Norton, Raymond S ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Assignment; Chemical shift; Insulin like growth factor; Nuclear magnetic resonance; Solution properties

Indexed keywords

CARBON 13; NITROGEN 15; SOMATOMEDIN C;

ARTICLE; CONTROLLED STUDY; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE DEPENDENCE;

HUMANS; HYDROGEN-ION CONCENTRATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; SOLUTIONS; TEMPERATURE;

EID: 67349153102     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.10.003     Document Type: Article

References (42)

1. Denley A., Cosgrove L.J., Booker G.W., Wallace J.C., and Forbes B.E. Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 16 (2005) 421-439
2. Cohick W.S., and Clemmons D.R. The insulin-like growth factors. Annu. Rev. Physiol. 55 (1993) 131-153
3. Bach L.A., Headey S.J., and Norton R.S. IGF-binding proteins - the pieces are falling into place. Trends Endocrinol. Metab. 16 (2005) 228-234
4. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocrinol. Rev. 23 (2002) 824-854
5. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4 (2004) 505-518
6. Ranke M.B. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance. Trends Endocrinol. Metab. 16 (2005) 190-197
7. Carrick F.E., Hinds M.G., McNeil K.A., Wallace J.C., Forbes B.E., and Norton R.S. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance. J. Mol. Endocrinol. 34 (2005) 685-698
8. Cooke R.M., Harvey T.S., and Campbell I.D. Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry 30 (1991) 5484-5491
9. Headey S.J., Keizer D.W., Yao S., Wallace J.C., Bach L.A., and Norton R.S. Binding site for the C-domain of insulin-like growth factor (IGF) binding protein-6 on IGF-II; implications for inhibition of IGF actions. FEBS Lett. 568 (2004) 19-22
10. Hua Q.X., Mayer J.P., Jia W., Zhang J., and Weiss M.A. The folding nucleus of the insulin superfamily: a flexible peptide model foreshadows the native state. J. Biol. Chem. 281 (2006) 28131-28142
11. Jansson M., Andersson G., Uhlen M., Nilsson B., and Kordel J. The insulin-like growth factor (IGF) binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis. J. Biol. Chem. 273 (1998) 24701-24707
12. 15 N-labelled human long-[Arg-3]-insulin-like growth factor 1 by multidimensional NMR spectroscopy. FEBS Lett. 420 (1997) 97-102
13. Laajoki L.G., Francis G.L., Wallace J.C., Carver J.A., and Keniry M.A. Solution structure and backbone dynamics of long-[Arg(3)]-insulin-like growth factor-I. J. Biol. Chem. 275 (2000) 10009-10015
14. 1H NMR assignment and secondary structure of human insulin-like growth factor-I (IGF-I) in solution. J. Biochem. 111 (1992) 529-536
15. Schaffer M.L., Deshayes K., Nakamura G., Sidhu S., and Skelton N.J. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor-I. Biochemistry 42 (2003) 9324-9334
16. Terasawa H., Kohda D., Hatanaka H., Nagata K., Higashihashi N., Fujiwara H., Sakano K., and Inagaki F. Solution structure of human insulin-like growth factor-II; recognition sites for receptors and binding proteins. EMBO J. 13 (1994) 5590-5597
17. Torres A.M., Forbes B.E., Aplin S.E., Wallace J.C., Francis G.L., and Norton R.S. Solution structure of human insulin-like growth factor-II. Relationship to receptor and binding protein interactions. J. Mol. Biol. 248 (1995) 385-401
18. Kuang Z., Yao S., Keizer D.W., Wang C.C., Bach L.A., Forbes B.E., Wallace J.C., and Norton R.S. Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2). J. Mol. Biol. 364 (2006) 690-704
19. Kuang Z., Yao S., McNeil K.A., Thompson J.A., Bach L.A., Forbes B.E., Wallace J.C., and Norton R.S. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding. Biochemistry 46 (2007) 13720-13732
20. 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 6 (1995) 135-140
21. Bartels C., Xia T.H., Billeter M., Güntert P., and Wüthrich K. The program XEASY for computer-supported NMR spectral-analysis of biological macromolecules. J. Biomol. NMR 6 (1995) 1-10
22. Sattler M., Schleucher J., and Griesinger C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Progr. NMR Spectrosc. 34 (1999) 93-158
23. Diercks T., Coles M., and Kessler H. An efficient strategy for assignment of cross-peaks in 3D heteronuclear NOESY experiments. J. Biomol. NMR 15 (1999) 177-180
24. Yao S., Babon J.J., and Norton R.S. Protein effective rotational correlation times from translational self-diffusion coefficients measured by PFG-NMR. Biophys. Chem. 136 (2008) 145-151
25. Wilkins D.K., Grimshaw S.B., Receveur V., Dobson C.M., Jones J.A., and Smith L.J. Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques. Biochemistry 38 (1999) 16424-16431
26. Brzozowski A.M., Dodson E.J., Dodson G.G., Murshudov G.N., Verma C., Turkenburg J.P., de Bree F.M., and Dauter Z. Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. Biochemistry 41 (2002) 9389-9397
27. Garcia de la Torre J., Huertas M.L., and Carrasco B. HYDRONMR: prediction of NMR relaxation of globular proteins from atomic-level structures and hydrodynamic calculations. J. Magn. Reson. 147 (2000) 138-146
28. Vajdos F.F., Ultsch M., Schaffer M.L., Deshayes K.D., Liu J., Skelton N.J., and de Vos A.M. Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions. Biochemistry 40 (2001) 11022-11029
29. Altieri A.A., Hinton D.P., and Byrd R.A. Association of biomolecular systems via pulsed field gradient NMR self-diffusion measurements. J. Am. Chem. Soc. 117 (1995) 7566-7567
30. 1H NMR titration shifts of amide proton resonances in polypeptide chains. FEBS Lett. 77 (1977) 11-14
31. 1H NMR study. Biopolymers 27 (1988) 1143-1157
32. Keim P., Vigna R.A., Morrow J.S., Marshall R.C., and Gurd F.R. Carbon 13 nuclear magnetic resonance of pentapeptides of glycine containing central residues of serine, threonine, aspartic and glutamic acids, asparagine, and glutamine. J. Biol. Chem. 248 (1973) 7811-7818
33. Bagley C.J., May B.L., Szabo L., McNamara P.J., Ross M., Francis G.L., Ballard F.J., and Wallace J.C. A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide. Biochem. J. 259 (1989) 665-671
34. Magee B.A., Shooter G.K., Wallace J.C., and Francis G.L. Insulin-like growth factor-I and its binding proteins: a study of the binding interface using B-domain analogues. Biochemistry 38 (1999) 15863-15870
35. Gauguin L., Delaine C., Alvino C.L., McNeil K.A., Wallace J.C., Forbes B.E., and De Meyts P. Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. J. Biol. Chem. 283 (2008) 20821-20829
36. Xu B., Hua Q.X., Nakagawa S.H., Jia W., Chu Y.C., Katsoyannis P.G., and Weiss M.A. A cavity-forming mutation in insulin induces segmental unfolding of a surrounding α-helix. Protein Sci. 11 (2002) 104-116
37. Hua Q.X., Chu Y.C., Jia W., Phillips N.F., Wang R.Y., Katsoyannis P.G., and Weiss M.A. Mechanism of insulin chain combination. Asymmetric roles of A-chain α-helices in disulfide pairing. J. Biol. Chem. 277 (2002) 43443-43453
38. Hua Q.X., Nakagawa S.H., Jia W., Huang K., Phillips N.B., Hu S.Q., and Weiss M.A. Design of an active ultrastable single-chain insulin analog: synthesis, structure, and therapeutic implications. J. Biol. Chem. 283 (2008) 14703-14716
39. Hua Q.X., Shoelson S.E., Kochoyan M., and Weiss M.A. Receptor binding redefined by a structural switch in a mutant human insulin. Nature 354 (1991) 238-241
40. Dong J., Wan Z., Popov M., Carey P.R., and Weiss M.A. Insulin assembly damps conformational fluctuations: Raman analysis of amide I linewidths in native states and fibrils. J. Mol. Biol. 330 (2003) 431-442
41. Hua Q.X., Nakagawa S., Hu S.Q., Jia W., Wang S., and Weiss M.A. Toward the active conformation of insulin: stereospecific modulation of a structural switch in the B chain. J. Biol. Chem. 281 (2006) 24900-24909
42. Szyperski T., Yeh D.C., Sukumaran D.K., Moseley H.N., and Montelione G.T. Reduced-dimensionality NMR spectroscopy for high-throughput protein resonance assignment. Proc. Natl. Acad. Sci. USA 99 (2002) 8009-8014